Life sciences · Preprint
arXiv · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
A medical model's benchmark score does not establish that the same conclusion holds under a different evaluation. This study tests whether claims about model ranking, score reliability and screening performance survive changes in cohort, prompt, negative spectrum, specified prevalence and operating threshold. We audit three medical vision-language models (BioMedCLIP, CheXficient, and MedSigLIP) and a general-domain OpenCLIP comparator on 12,200 chest radiograph records from four datasets (Montgomery, Shenzhen, TBX11K, and VinDr-CXR). Five fixed prompt families yield 244,000 model--image--prompt scores. No model leads every cohort and reliability criterion. Prompt-family changes alter AUROC in 21 of 48 multiplicity-controlled comparisons. Replacing healthy controls with sick non-tuberculosis controls reduces AUROC by 0.075--0.306 across all four models. On VinDr-CXR, the three medical models distinguish tuberculosis from no-finding controls substantially better than from pneumonia or lung tumor; their AUROC point estimates for both named diseases fall below 0.5. CheXficient has documented VinDr-CXR pretraining exposure, which limits the interpretation of its results. Thresholds chosen for 95\% sensitivity on TBX11K training retain that constraint by point estimate in only four of sixteen target evaluations. A five-seed supervised source model reaches 0.999 AUROC on TBX11K validation but 0.629 on each of two external cohorts. Conservative exclusion of perceptual-overlap candidates narrows this gap without closing it. These retrospective, single-task results show that discrimination, score reliability and threshold retention support different portability claims. Evidence for chest X-ray tuberculosis screening should identify the complete evaluation specification rather than attribute clinical portability to a checkpoint alone.